Lack of EPO tests scotched three world records: IAAF
BEIJING (Reuters) – Three world records have failed to make
the official lists this year because organizers neglected to
test for erythropoietin (EPO), the International Association of
Athletics Federations (IAAF) said.
IAAF general secretary Pierre Weiss reiterated tests for
the banned blood-boosting drug must follow all world
record-breaking performances, saying a lack of knowledge about
compulsory testing had lead to the rejection of the records.
“This is not a new decision. It has been known for two
years, but it would seem that this information is not known
because we had to refuse applications for three world records
this year already,” Weiss told reporters.
A lack of EPO analysis had deprived the U.S. 4x400m relay
team of an indoor world record set in February and canceled
twice Olympic 10,000 meters champion Haile Gebrselassie’s 25km
world mark of 1:11.37 set in the Netherlands in March.
A junior men’s 10km race walking record set by Russian
Sergey Morozov in February had also been withdrawn, Weiss said.
Weiss said that investigations into sprinter Marion Jones,
who tested positive for a banned substance at the U.S. track
championships in June, were continuing.
Jones, who won three gold medals at the 2000 Sydney
Olympics, said on Monday she had requested her ‘B’ test be
If her ‘B’ sample is positive, she faces a two-year ban
from the sport under anti-doping rules.
Jones, 30, has repeatedly denied taking
performance-enhancing substances and had never previously
failed a doping test.